How to Advance Cancer Care for Native Americans

How to Advance Cancer Care for Native America...

Up next

Navigating Therapeutic Advances in EGFR-Mutated NSCLC

Dr. Monty Pal and Dr. Vamsi Velcheti discuss the evolving treatment landscape in EGFR-mutated non-small cell lung cancer, including landmark trials like FLAURA2, novel drug therapies, and the growing importance of ctDNA and MRD testing. TRANSCRIPT Dr. Monty Pal: Hello, and welcom ...  Show more

Highlights From the 2026 ASCO GU Cancers Symposium

Dr. Monty Pal and Dr. Andrea Apolo discuss practice-changing studies and other novel approaches in bladder, kidney, and prostate cancers that were presented at the 2026 ASCO Genitourinary Cancers Symposium. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcas ...  Show more

Recommended Episodes

Cancer Prevention with Dr. Leigh Erin Connealy, MD
Longevity Optimization with Kayla Barnes-Lentz

Today I am speaking with Dr. Leigh Erin Connealy, MD. Dr. Connealy is absolutely amazing, and I was so interested to have her on the podcast because of her incredible experience and philosophy on cancer prevention.

We discuss cancer ra ...

  Show more

Revolutionizing Cancer Care and Thriving with Dr. Nasha Winters
Well Beyond 40

"Cancer doesn't have to be a death sentence. It can be an awakening to a whole new way of living." - Dr. Nasha Winters Today, I sit down with Dr. Nasha Winters for an eye-opening conversation about revolutionizing cancer care. From her own journey surviving stage 4 ovarian cance ...  Show more

Interview: Could we detect breast cancer with a fingerprint? with Dr. Dhivya Srinivasa
TED Health

Breast cancer is the most common cancer among women globally. And yet, many people pass up opportunities to get screened for the disease, often because of the invasive and sometimes painful process of mammograms. Chemist and professor Simona Francese presents a potentially ground ...  Show more

Tackling bias in health
People Fixing the World

Bias in the way medical research is carried out means that new medicines for diseases such as cancer – as well as the tools used to diagnose patients with some conditions – are disproportionally tested on people of European heritage. This can lead to those not represented in the ...  Show more